Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-08-27 | 2023-07-05 | 144747 |
TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-06-16 | 2023-07-06 | 195036 |
TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2023-06-19 | 2024-03-18 | 195649 |
TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2023-06-20 | 2024-03-18 | 195879 |
TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2021-09-16 | 2024-03-18 | 145783 |
TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86930 |
TEVA-LATANOPROST | 50MCG | SOLUTION | Actual shortage | 2024-02-08 | 2024-03-21 | 218963 |
TEVA-LATANOPROST | 50MCG | SOLUTION | Actual shortage | 2024-05-09 | 2024-05-09 | 227477 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2019-07-02 | 2019-08-06 | 88186 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195864 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-07-27 | 2023-10-26 | 200249 |
TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154723 |
TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2020-01-09 | 2020-03-05 | 102901 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-06-18 | 2020-07-23 | 118256 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-22 | 2021-04-21 | 132264 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-28 | 2021-04-29 | 132660 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-09-30 | 2021-10-21 | 146462 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154726 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113040 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-01-09 | 2020-03-05 | 102911 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |